Article Details

BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of ...

Retrieved on: 2021-01-22 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

BirchBioMed Inc. Announces Positive Topline Data from Phase 2 Study of FS2 for Treatment of .... View article details on hiswai:

Excerpt

Secondary data analysis using POSAS showed dramatic patient satisfaction with FS2 patients scoring a 51% improvement with FS2 versus ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up